News & Updates
Filter by Specialty:
One-time phone consultation compares favourably to in-person care for T2D management
A single phone consultation performs as well as traditional face-to-face consultations in terms of helping individuals with type 2 diabetes (T2D) achieve short-term glycaemic control, as shown in a study from Singapore.
One-time phone consultation compares favourably to in-person care for T2D management
18 May 2023Conventional vs shorter ocrelizumab infusions: which way to go?
In the ENSEMBLE PLUS study, there appears to be no difference in terms of the frequency and severity of infusion-related reactions (IRRs) between the conventional and shorter infusions of ocrelizumab for the treatment of early relapsing-remitting multiple sclerosis (RRMS). However, patients gravitated towards the shorter regimen more than the conventional method.
Conventional vs shorter ocrelizumab infusions: which way to go?
18 May 2023SGLT2 inhibitors reduce HCC risk in T2DM patients with CHB
The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors is associated with a reduced risk of incident hepatocellular carcinoma (HCC) in patients with coexisting type 2 diabetes mellitus (T2DM) and chronic hepatitis B (CHB), a territory-wide cohort study in Hong Kong has shown.